Back
Roche Holding AG Vs. NLS Pharmaceutics Industry Stock Comparison
Sell
22
RHHVF
Roche Holding AG
Last Price:
282.14
Seasonality Move:
2.53%
Sell
24
NLSP
NLS Pharmaceutics
Last Price:
3.30
Seasonality Move:
34.69%
Sell
22
Roche Holding AG (RHHVF)
is a Sell
Is Roche Holding AG a Buy, Sell or Hold?
- The current Roche Holding AG [RHHVF] share price is $279.58. The Score for RHHVF is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- RHHVF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $3.29. The Score for NLSP is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RHHVF Stock Price Chart
What is Roche Holding AG's stock price today?
-
The Roche Holding AG share price today is $279.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RHHVF is experiencing selling pressure, which indicates risk of future bearish movement.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $3.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight selling pressure.
RHHVF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -8.25 | Sell |
| Relative Strength Index (14 RSI): | 26.94 | Sell |
| Chaikin Money Flow: | -707 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (291.77 - 317.17) | Sell |
| Bollinger Bands (100): | (294.2 - 327.24) | Sell |
NLSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.41 | Sell |
| Relative Strength Index (14 RSI): | 35.49 | Sell |
| Chaikin Money Flow: | -12070 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.45 - 4.61) | Sell |
| Bollinger Bands (100): | (4.31 - 7.63) | Sell |
RHHVF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 288.85 | Sell |
| 20-day SMA: | 302.24 | Sell |
| 50-day SMA: | 308.73 | Sell |
| 200-day SMA: | 283.59 | Sell |
| 8-day EMA: | 288 | Sell |
| 20-day EMA: | 297.57 | Sell |
| 50-day EMA: | 305.32 | Sell |
| 200-day EMA: | 295.28 | Sell |
NLSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.45 | Sell |
| 20-day SMA: | 3.8 | Sell |
| 50-day SMA: | 4.59 | Sell |
| 200-day SMA: | 7.43 | Sell |
| 8-day EMA: | 3.43 | Sell |
| 20-day EMA: | 3.81 | Sell |
| 50-day EMA: | 4.56 | Sell |
| 200-day EMA: | 9.37 | Sell |
Roche Holding AG Earnings Growth & RHHVF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Roche Holding AG Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NLS Pharmaceutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||